Home / Pharma Healthcare / Clovis Oncology Inc (CLVS) - Financial and Strategic SWOT Analysis Review

Clovis Oncology Inc (CLVS) - Financial and Strategic SWOT Analysis Review

  • Id : RNR-95284
  • Category : Pharma Healthcare
  • Publish Date : 22-Jun-2017
  • Pages : 46
  • Format : PDF
License Type

Clovis Oncology Inc (CLVS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company?s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company?s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description ? A detailed description of the company?s operations and business divisions.
- Corporate strategy ? Analyst?s summarization of the company?s business strategy.
- SWOT Analysis ? A detailed analysis of the company?s strengths, weakness, opportunities and threats.
- Company history ? Progression of key events associated with the company.
- Major products and services ? A list of major products, services and brands of the company.
- Key competitors ? A list of key competitors to the company.
- Key employees ? A list of the key executives of the company.
- Executive biographies ? A brief summary of the executives? employment history.
- Key operational heads ? A list of personnel heading key departments/functions.
- Important locations and subsidiaries ? A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities ? A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years ? The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods ? The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.


Clovis Oncology Inc (Clovis) is a biopharmaceutical company that acquires, develops and commercializes new anti-cancer agents. The company's development programs are targeted at specific cancer indications, combining personalized medicine with companion diagnostics. It develops and commercializes rights for rociletinib, rucaparib and holds right in the US and Japan for lucitanib. The company has collaboration agreements with various companies such as Celgene Avilomics Research Inc.; Advenchen Laboratories LLC; Pfizer Inc. and Les Laboratoires Servier for the development and commercialization of its product candidates. The company operates offices in offices in San Francisco and California, the US; Cambridge, the UK; and Milan, Italy. Clovis is headquartered in Boulder, Colorado, the US.

Clovis Oncology Inc Key Recent Developments

May 03,2017: Clovis Oncology Announces First Quarter 2017 Operating Results
Feb 22,2017: Clovis Oncology Announces 2016 Operating Results
Nov 03,2016: Clovis Oncology Announces Q3 2016 Operating Results and Corporate Update
Aug 08,2016: Clovis Oncology Announces Q2 2016 Operating Results and Corporate Update
May 05,2016: Clovis Oncology Announces Q1 2016 Operating Results and Corporate Update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company?s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors? business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company?s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies? strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company